HPLC analysis of antihypertensive drugs in combined therapies
A beginner's guide for HPLC method development & validation
978-620-3-04248-1
620304248X
92
2020-11-24
54,90 €
eng
https://images.our-assets.com/cover/230x230/9786203042481.jpg
https://images.our-assets.com/fullcover/230x230/9786203042481.jpg
https://images.our-assets.com/cover/2000x/9786203042481.jpg
https://images.our-assets.com/fullcover/2000x/9786203042481.jpg
The use of antihypertensive agents in combination is common. To decrease the pill burden, lower the prescription costs and improve patient compliance; combination antihypertensive therapies compile two or more active drugs. Thiazide diuretics are frequently recommended as one of the first-line therapy for the treatment of hypertension in combination with other class of antihypertensive drugs, i.e. angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, calcium channel blocker and β-blocker. The book demonstrates strategies employed in simultaneous analysis of amlodipine, olmesartan, atenolol, telmisartan, hydrochlorothiazide and propanolol in combined dosage forms for treatment of hypertension. This book is suitable as a reference book for postgraduate and doctoral research scholars. The book can be considered as a guide to the beginners for HPLC method development and validation.
https://morebooks.de/books/hu/published_by/lap-lambert-academic-publishing/47/products
Gyógyszerészet
https://morebooks.de/store/hu/book/hplc-analysis-of-antihypertensive-drugs-in-combined-therapies/isbn/978-620-3-04248-1